5.35
-1.83%
Close of 9 Nov 2026, in EUR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Laboratoires Euromedis
Its shares trade on Euronext Paris under the ticker ALEMG.PA. It has been listed since 27 March 2000. In the fiscal year to 31 December 2025, it reported revenue of €40.8m and a net loss of €131,774. At that date it held total assets of €39.5m and shareholders' equity of €16.4m.
Euromedis Groupe SA specializes in the design, manufacturing, and distribution of medical equipment. The company is headquartered in Neuilly-Sous-Clermont, Hauts-De-France. The company went IPO on 2000-03-27. The firm's product portfolio include products, such as syringes and needles; surgical equipment, such as catheters, instrumentation and compresses; gloves; hygiene products, comprising disposable clothing, masks and paper towel products, and pharmaceutical equipment, offering cotton wool and thermometers. Euromedis Groupe SA exports its products to Europe and Africa.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 27 Mar 2000
- Employees
- 232
- Website
- euromedis.fr ↗
Leadership
Pay as last reported
- Mr. Mathieu RoturierChairman of the Board, Chief Executive Officer€116,253
- Mr. Joseph AsselinDirector - Representative of NINA, since 2019
- Mr. Florent BaillergeauDirector - Representative of Yoko
- Mrs. Marion TramierDirector - Representative of KELLY, since 2019
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Euromedis Groupe SA has a strong market presence, allowing them to have a wide customer base and strong brand recognition.
- The company has a team of skilled and experienced professionals, enabling them to consistently deliver high-quality products and services.
- Euromedis Groupe SA has a diverse product portfolio, catering to various healthcare needs and providing a competitive advantage.
Weaknesses
- One of the weaknesses of Euromedis Groupe SA is their dependence on external suppliers for raw materials, which can impact their supply chain and production processes.
- The company may face challenges in adapting to rapidly changing technology trends, potentially leading to a lag in innovation compared to competitors.
- Euromedis Groupe SA operates in a highly regulated industry, which could result in increased compliance costs and potential legal issues.
Opportunities
- The growing demand for healthcare products and services presents an opportunity for Euromedis Groupe SA to expand their market share and revenue.
- The company can explore partnerships and collaborations with healthcare organizations to enhance their product offerings and enter new markets.
- Euromedis Groupe SA can leverage advancements in technology to develop innovative solutions that better meet the needs of their customers.
Threats
- Intense competition within the healthcare industry poses a threat to Euromedis Groupe SA's market position and profitability.
- Economic fluctuations and government policies can impact the purchasing power and healthcare expenditure, affecting the company's sales and revenue.
- Emerging substitute products or alternative therapies may reduce the demand for some of Euromedis Groupe SA's existing products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.